{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:13:53Z","timestamp":1774617233883,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03770-5","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:54:15Z","timestamp":1771552455000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Regional differences in clinical manifestations of antisynthetase syndrome: a comparison between Asian and European cohorts"],"prefix":"10.1186","volume":"28","author":[{"given":"Tomoya","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ototake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisho","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Moteki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Kanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-6627","authenticated-orcid":false,"given":"Yukie","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"3770_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE, Fujimoto M, Vencovsky J, Aggarwal R, Holmqvist M, Christopher-Stine L, et al. Idiopathic inflammatory myopathies. Nat Rev Dis Primers. 2021;7:86. https:\/\/doi.org\/10.1038\/s41572-021-00321-x.","journal-title":"Nat Rev Dis Primers"},{"key":"3770_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","volume":"14","author":"NJ McHugh","year":"2018","unstructured":"McHugh NJ, Tansley SL. Autoantibodies in myositis. Nat Rev Rheumatol. 2018;14:290\u2013302. https:\/\/doi.org\/10.1038\/nrrheum.2018.56.","journal-title":"Nat Rev Rheumatol"},{"key":"3770_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2397198320902667","volume":"5","author":"K Huang","year":"2020","unstructured":"Huang K, Aggarwal R. Antisynthetase syndrome: a distinct disease spectrum. J Scleroderma Relat Disord. 2020;5:178\u201391. https:\/\/doi.org\/10.1177\/2397198320902667.","journal-title":"J Scleroderma Relat Disord"},{"key":"3770_CR4","doi-asserted-by":"publisher","first-page":"1759720X2110324","DOI":"10.1177\/1759720X211032457","volume":"13","author":"M Kuwana","year":"2021","unstructured":"Kuwana M, Gil-Vila A, Selva-O\u2019Callaghan A. Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis. 2021;13:1759720X211032457. https:\/\/doi.org\/10.1177\/1759720X211032457.","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"3770_CR5","doi-asserted-by":"publisher","first-page":"rkae049","DOI":"10.1093\/rap\/rkae049","volume":"8","author":"S Yamamoto","year":"2024","unstructured":"Yamamoto S, Yoshida A, Okazaki Y, Gono T, Kuwana M. Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis. Rheumatol Adv Pract. 2024;8:rkae049. https:\/\/doi.org\/10.1093\/rap\/rkae049.","journal-title":"Rheumatol Adv Pract"},{"key":"3770_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/art.43038","volume":"77","author":"S Faghihi-Kashani","year":"2025","unstructured":"Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, Rozza D, Loganathan A, et al. Clinical characteristics of anti-synthetase syndrome: analysis from the classification criteria for Anti-synthetase syndrome project. Arthritis Rheumatol. 2025;77:477\u201389. https:\/\/doi.org\/10.1002\/art.43038.","journal-title":"Arthritis Rheumatol"},{"key":"3770_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaad.2019.06.1309","volume":"82","author":"ME DeWane","year":"2020","unstructured":"DeWane ME, Waldman R, Lu J. Dermatomyositis: clinical features and pathogenesis. J Am Acad Dermatol. 2020;82:267\u201381. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.1309.","journal-title":"J Am Acad Dermatol"},{"key":"3770_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/14397595.2018.1452353","volume":"29","author":"M Ueki","year":"2019","unstructured":"Ueki M, Kobayashi I, Takezaki S, Tozawa Y, Okura Y, Yamada M, et al. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies. Mod Rheumatol. 2019;29:351\u20136. https:\/\/doi.org\/10.1080\/14397595.2018.1452353.","journal-title":"Mod Rheumatol"},{"key":"3770_CR9","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1093\/rheumatology\/keaa429","volume":"60","author":"G Mamyrova","year":"2021","unstructured":"Mamyrova G, Kishi T, Shi M, Targoff IN, Huber AM, Curiel RV, et al. Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America. Rheumatol (Oxf Engl). 2021;60:1839\u201349. https:\/\/doi.org\/10.1093\/rheumatology\/keaa429.","journal-title":"Rheumatol (Oxf Engl)"},{"key":"3770_CR10","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138:1464\u201374. https:\/\/doi.org\/10.1378\/chest.10-0180.","journal-title":"Chest"},{"key":"3770_CR11","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.40320","volume":"69","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 European league against Rheumatism\/American college of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 2017;69:2271\u201382. https:\/\/doi.org\/10.1002\/art.40320.","journal-title":"Arthritis Rheumatol"},{"key":"3770_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292:344\u20137. https:\/\/doi.org\/10.1056\/NEJM197502132920706.","journal-title":"N Engl J Med"},{"key":"3770_CR13","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626\u201336. https:\/\/doi.org\/10.1067\/mjd.2002.120621.","journal-title":"J Am Acad Dermatol"},{"key":"3770_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1183\/13993003.00150-2015","volume":"46","author":"A Fischer","year":"2015","unstructured":"Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, Du Bois RM, et al. An official European respiratory society\/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46:976\u201387. https:\/\/doi.org\/10.1183\/13993003.00150-2015.","journal-title":"Eur Respir J"},{"key":"3770_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.nmd.2019.09.014","volume":"29","author":"A Selva-O\u2019Callaghan","year":"2019","unstructured":"Selva-O\u2019Callaghan A, Ros J, Gil-Vila A, Vila-Pijoan G, Trallero-Aragu\u00e1s E, Pinal-Fernandez I. Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes. Neuromuscul Disord. 2019;29:819\u201325. https:\/\/doi.org\/10.1016\/j.nmd.2019.09.014.","journal-title":"Neuromuscul Disord"},{"key":"3770_CR16","doi-asserted-by":"publisher","first-page":"6849","DOI":"10.3390\/jcm12216849","volume":"12","author":"T Sodsri","year":"2023","unstructured":"Sodsri T, Petnak T, Ngamjanyaporn P. Clinical characteristics of anti-synthetase syndrome and variables associated with interstitial lung disease and mortality: A retrospective cohort study. J Clin Med. 2023;12:6849. https:\/\/doi.org\/10.3390\/jcm12216849.","journal-title":"J Clin Med"},{"key":"3770_CR17","doi-asserted-by":"publisher","first-page":"e1085","DOI":"10.1002\/iid3.1085","volume":"11","author":"D Zhang","year":"2023","unstructured":"Zhang D, Wang H, Zhou X, Yang J, Liu Y, Wang W, et al. Clinical characteristics and prognostic analysis of idiopathic inflammatory myopathy with positive anti-aminoacyl-tRNA synthetase antibodies: A single center experience. Immun Inflamm Dis. 2023;11:e1085. https:\/\/doi.org\/10.1002\/iid3.1085.","journal-title":"Immun Inflamm Dis"},{"key":"3770_CR18","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10067-022-06404-8","volume":"42","author":"R Wang","year":"2023","unstructured":"Wang R, Zhao Y, Qi F, Wu X, Wang Y, Xu Y, et al. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China. Clin Rheumatol. 2023;42:703\u20139. https:\/\/doi.org\/10.1007\/s10067-022-06404-8.","journal-title":"Clin Rheumatol"},{"key":"3770_CR19","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1093\/rheumatology\/kead481","volume":"63","author":"RM Hum","year":"2024","unstructured":"Hum RM, Lilleker JB, Lamb JA, Oldroyd AGS, Wang G, Wedderburn LR, et al. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry. Rheumatol (Oxf Engl). 2024;63:2093\u2013100. https:\/\/doi.org\/10.1093\/rheumatology\/kead481.","journal-title":"Rheumatol (Oxf Engl)"},{"key":"3770_CR20","doi-asserted-by":"publisher","first-page":"102951","DOI":"10.1016\/j.jaut.2022.102951","volume":"134","author":"C Preger","year":"2023","unstructured":"Preger C, Notarnicola A, Hellstr\u00f6m C, Wigren E, Fernandes-Cerqueira C, Kvarnstr\u00f6m M, et al. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies. J Autoimmun. 2023;134:102951. https:\/\/doi.org\/10.1016\/j.jaut.2022.102951.","journal-title":"J Autoimmun"},{"key":"3770_CR21","first-page":"190","volume":"1","author":"P Martins","year":"2022","unstructured":"Martins P, Dourado E, Melo AT, Sam\u00f5es B, Sousa M, Freitas R, et al. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome. ARP Rheumatol. 2022;1:190\u20136.","journal-title":"ARP Rheumatol"},{"key":"3770_CR22","doi-asserted-by":"publisher","first-page":"e60442","DOI":"10.1371\/journal.pone.0060442","volume":"8","author":"Y Hamaguchi","year":"2013","unstructured":"Hamaguchi Y, Fujimoto M, Matsushita T, Kaji K, Komura K, Hasegawa M, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. PLoS ONE. 2013;8:e60442. https:\/\/doi.org\/10.1371\/journal.pone.0060442.","journal-title":"PLoS ONE"},{"key":"3770_CR23","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3899\/jrheum.161480","volume":"44","author":"J Shi","year":"2017","unstructured":"Shi J, Li S, Yang H, Zhang Y, Peng Q, Lu X, et al. Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies. J Rheumatol. 2017;44:1051\u20137. https:\/\/doi.org\/10.3899\/jrheum.161480.","journal-title":"J Rheumatol"},{"key":"3770_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.semarthrit.2020.11.009","volume":"51","author":"KY Sun","year":"2021","unstructured":"Sun KY, Fan Y, Wang YX, Zhong YJ, Wang GF. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020. Semin Arthritis Rheum. 2021;51:175\u201391. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.11.009.","journal-title":"Semin Arthritis Rheum"},{"key":"3770_CR25","doi-asserted-by":"publisher","first-page":"R138","DOI":"10.1186\/ar4600","volume":"16","author":"SL Tansley","year":"2014","unstructured":"Tansley SL, Betteridge ZE, Gunawardena H, Jacques TS, Owens CM, Pilkington C, et al. Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study. Arthritis Res Ther. 2014;16:R138. https:\/\/doi.org\/10.1186\/ar4600.","journal-title":"Arthritis Res Ther"},{"key":"3770_CR26","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1093\/rheumatology\/keab108","volume":"60","author":"Y Yamasaki","year":"2021","unstructured":"Yamasaki Y, Kobayashi N, Akioka S, Yamazaki K, Takezaki S, Nakaseko H, et al. Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study. Rheumatol (Oxf Engl). 2021;60:4821\u201331. https:\/\/doi.org\/10.1093\/rheumatology\/keab108.","journal-title":"Rheumatol (Oxf Engl)"},{"key":"3770_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N, Koontz DC, Lucas M, Ascherman DP, et al. Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis. 2014;73:227\u201332. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201800.","journal-title":"Ann Rheum Dis"},{"key":"3770_CR28","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/44853","volume":"401","author":"Complete sequence and gene map of a human major histocompatibility complex","year":"1999","unstructured":"Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature. 1999;401:921\u20133. https:\/\/doi.org\/10.1038\/44853.","journal-title":"Nature"},{"key":"3770_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1056\/NEJM200009143431106","volume":"343","author":"J Klein","year":"2000","unstructured":"Klein J, Sato A. The HLA system. Second of two parts. N Engl J Med. 2000;343:782\u20136. https:\/\/doi.org\/10.1056\/NEJM200009143431106.","journal-title":"N Engl J Med"},{"key":"3770_CR30","doi-asserted-by":"publisher","first-page":"105115","DOI":"10.1016\/j.jbspin.2020.105115","volume":"88","author":"S Remuzgo-Mart\u00ednez","year":"2021","unstructured":"Remuzgo-Mart\u00ednez S, Atienza-Mateo B, Ocejo-Vinyals JG, Pulito-Cueto V, Prieto-Pe\u00f1a D, Genre F, et al. HLA association with the susceptibility to anti-synthetase syndrome. Joint Bone Spine. 2021;88:105115. https:\/\/doi.org\/10.1016\/j.jbspin.2020.105115.","journal-title":"Joint Bone Spine"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03770-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03770-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:29:50Z","timestamp":1774614590000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03770-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3770"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03770-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Yokohama City University (approval no. B190800045). Consent to participate was not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}